Koichi Kameda is a sociologist and a lawyer who works on pharmaceutical innovation in the Global South. His Ph.D. thesis, completed at the Ecole des Hautes Etudes en Sciences Sociales (EHESS), funded by the French Agency for Research on Emerging Infectious Diseases (ANRS | Maladies Infectieuses Emergentes) and Sidaction, under the supervision of Maurice Cassier and Marilena Corrêa, studied the development of in vitro diagnostics for infectious diseases in Brazil over the last three decades, as part of the country’s commitment to national technological development in the service of universal access to healthcare provision.

He is currently a post-doctoral researcher funded by the Institut Francilien Recherche Innovation Société (IFRIS) and affiliated to the Center for Populations and Development at the University of Paris (CEPED/Paris) where he investigates the Indian and Brazilian models of manufacturing and development of vaccines and diagnostics for emerging diseases, from mosquito-borne diseases (zika, dengue, chikungunya) to COVID-19. He also coordinates the project “CoBRATestes – Testing COVID-19 in Brazil”, funded by the ANRS (COV 28).

He is a visiting researcher at CSH-Delhi since March 21th, 2022.

Selected publications:
  • Kameda Koichi (2021) « Molecular Sovereignty: Building a Blood Screening Test for the Brazilian Nation », Medicine Anthropology Theory, 8 (2), p. 1-25. DOI: 10/gncwbr. http://www.medanthrotheory.org/article/view/5122.
  • Kameda Koichi, Kelly Ann H, Lezaun Javier and Löwy Ilana (2021) « Imperfect diagnosis: The truncated legacies of Zika testing », Social Studies of Science, p. 030631272110354. DOI : 10.1177/03063127211035492. http://journals.sagepub.com/doi/10.1177/03063127211035492.
  • Kameda Koïchi et Kessel Nils (2021) « Quels consensus?: La sécurité transfusionnelle en Allemagne et au Brésil », Cahiers Droit, Sciences & Technologies, 12, p. 97-115. DOI : 10.4000/cdst.3483. http://journals.openedition.org/cdst/3483.
  • Kameda Koichi, Barbeitas Mady, Caetano Rosângela, Löwy Ilana, Oliveira Ana Claudia Dias de, Corrêa Marilena Cordeiro Dias Villela et Cassier Maurice (2021) « Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified National Health System », Cadernos de Saúde Pública, 37 (3), p. e00277420. DOI : 10.1590/0102-311×00277420. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2021000306001&tlng=en.
  • KAMEDA, Koichi (2019). The introduction of nucleic acid tests (NAT) for blood screening in the Brazilian public healthcare system: negotiating and assembling technologies for the nationalization of ‘NAT brasileiro’. In: Cassier, M. Corrêa, M. (Org.). Health innovation and social justice in Brazil. Palgrave Ed.

You may also like...